# Violeta Serra

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/violeta-serra/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,511 |
| Field | PARP inhibition in cancer therapy |
| h-index | 61 |
| i10-index | 113 |
| Last Known Institution | Hebron University |
| OpenAlex ID | https://openalex.org/A5073423716 |
| ORCID iD | https://orcid.org/0000-0001-6620-1065 |
| Works | 816 |

## Researcher papers

- [Interrogating open issues in cancer precision medicine with patient-derived xenografts](https://scholariq.org/papers/interrogating-open-issues-in-cancer-precision-medicine-with-patient-derived/)
- [A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds](https://scholariq.org/papers/a-biobank-of-breast-cancer-explants-with-preserved-intra-tumor-heterogeneity-to/)
- [PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer](https://scholariq.org/papers/pi3k-inhibition-results-in-enhanced-estrogen-receptor-function-and-dependence-in/)

## Researcher topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Researcher university

- [Hebron University](https://scholariq.org/institutions/hebron-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.